Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  T.ACB.WS.U | ACB

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company’s segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Edmonton, Alberta; Bradford Ontario; Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.


TSX:ACB - Post by User

Bullboard Posts
Post by Kevelleon Jul 28, 2018 12:11am
96 Views
Post# 28380388

Auroras strategic location in Europe: Malta

Auroras strategic location in Europe: Malta

Aurora Cannabis Inc.’s (TSX:ACB) entry into the Maltese market is an important step for the Company as Malta is strategically located to serve export markets throughout Europe

July 27, 2018: Aurora Cannabis Inc. (TSX:ACB) Tuesday announced that it has received a Letter of Intent (LOI) from Malta Enterprise, signifying approval of its application for the establishment of a seed-to-pharma cannabis operation. A new subsidiary, Aurora Malta, will be formed with Aurora’s local Maltese partner Cherubino Ltd., which is the largest pharmaceutical wholesaler in the country with an operating history of more than 100 years. The new venture will have Aurora Cannabis as the majority shareholder. The proposed project will include the construction of a hybrid cultivation, manufacturing, and distribution facility.

This is the first cultivation LOI issued by the Maltese authorities to date. Aurora Cannabis will be allocated land for the development of its cannabis facility by Malta Industrial Parks Ltd. The production facility will be designed by Aurora Larssen Projects Ltd. (ALPS) and built using additional local expertise. Both the cultivation and processing operations will be accomplished as per EU GMP standards.

Through Pedanios, Aurora Cannabis has worked closely with its local partner Cherubino Ltd. to build up a concept for the cultivation of medicinal cannabis in accordance with the Maltese ‘Production of Cannabis for Medicinal and Research Purpose Act, 2018’. The Company is going to announce the final size and design of the facility shortly.

Aurora Cannabis Chief Global Business Development Officer Neil Belot remarked, “Aurora already was the first company to export medical cannabis to both Italy and Malta, and now are the first to receive approval for the production, processing, and distribution of cannabis in the country. Having an EU GMP compliant facility in Malta will position us well to serve multiple international markets, including Southern Europe and beyond. We are delighted to have Cherubino as our local partner, whose professionalism, reputation and standing in Malta were instrumental in establishing a local presence. We look forward to creating a thriving Maltese business, generating significant employment opportunities, and serving medical patients with high-quality cannabis products.”

Aurora Cannabis Inc.’s entry into the Maltese market is an important step for the Company as Malta is strategically located to serve export markets throughout Europe. 

Bullboard Posts